logo

Inovio Pharmaceuticals Inc. (INO)



Trade INO now with
  Date
  Headline
9/28/2020 7:02:34 AM INOVIO Reports FDA Partial Clinical Hold For Planned Phase 2 / 3 Trial Of COVID-19 Vaccine Candidate INO-4800
9/8/2020 8:08:58 AM Thermo Fisher Scientific Signs LoI To Manufacture INOVIO's DNA COVID-19 Vaccine Candidate INO-4800
8/10/2020 4:08:08 PM INOVIO Q2 Loss/Shr $0.83 Vs Loss $0.30 Prior Year